Frequency Therapeutics Inc (FREQ)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
David L. Lucchino
Employees:
70
19 PRESIDENTIAL WAY, SUITE 203, WOBURN, MA 01801
781-315-4600

Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. The company's lead product candidate is FX-322, which is in Phase IIa clinical trial to treat the underlying cause of sensorineural hearing loss.

Data derived from most recent annual or quarterly report
Market Cap 12.915 Million Shares Outstanding35.287 Million Avg 30-day Volume 126.987 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS
Price to Revenue0.0 Debt to Equity0.7114 EBITDA-75.375 Million
Price to Book Value0.3377 Operating Margin0.0 Enterprise Value-10.785 Million
Current Ratio3.144 EPS Growth0 Quick Ratio3.025
1 Yr BETA 0.4534 52-week High/Low 5.59 / 0.35 Profit Margin0.0
Operating Cash Flow Growth18.9936 Altman Z-Score-5.6458 Free Cash Flow to Firm -49.388 Million
Earnings Report2023-08-09
View SEC Filings from FREQ instead.

View recent insider trading info

Frequency Therapeutics Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding FREQ (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding FREQ

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-01-27 by LUCCHINO DAVID L.
  • 4: filed on 2023-01-27 by MITRANO RICHARD J.
  • 4: filed on 2023-01-27 by MCCUBBIN QUENTIN
  • 4: filed on 2023-01-27 by LeBel Carl
  • 4: filed on 2023-01-27 by Loose Christopher R.
  • 4: filed on 2023-01-27 by ARNOLD WENDY S
  • 4: filed on 2022-08-19 by BARBERICH TIMOTHY J
  • 4: filed on 2022-08-19 by FELDMANN CYNTHIA L
  • 4: filed on 2022-08-19 by MARCUS JOEL S
  • 4: filed on 2022-08-19 by LANGER ROBERT

    • Events (8k)

  • 8-K: filed on 2023-06-06:
    Item 2.05: Cost Associated with Exit or Disposal Activities
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-12:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-10:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2023-03-29:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-02-13:
    Item 2.02: Results of Operations and Financial Condition
    Item 2.05: Cost Associated with Exit or Disposal Activities
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-12-13:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-08:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-09-12:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-12:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    LEBEL CARL CHIEF DEVELOPMENT OFFICER

    • Officer
    		 91,000 2023-01-26 3

    MITRANO RICHARD J. VP FINANCE & OPERATIONS

    • Officer
    		 91,000 2023-01-26 3

    LUCCHINO DAVID L. PRESIDENT AND CEO

    • Officer
    • Director
    		 280,000 2023-01-26 2

    LOOSE CHRISTOPHER R. CHIEF SCIENTIFIC OFFICER

    • Officer
    		 105,000 2023-01-26 3

    ARNOLD WENDY S CHIEF PEOPLE OFFICER

    • Officer
    		 91,000 2023-01-26 3

    MCCUBBIN QUENTIN CHIEF MANUFACTURING OFFICER

    • Officer
    		 105,000 2023-01-26 3

    BARBERICH TIMOTHY J

    • Director
    		 0 2022-08-17 2

    MARCUS JOEL S

    • Director
    		 0 2022-08-17 2

    LANGER ROBERT

    • Director
    		 0 2022-08-17 2

    FELDMANN CYNTHIA L

    • Director
    		 0 2022-08-17 2

    HUANG MICHAEL

    • Director
    		 0 2022-08-17 2

    COHEN MARC A

    • Director
    		 14,846 2022-06-21 1

    PFREUNDSCHUH PETER P. CHIEF FINANCIAL OFFICER

    • Officer
    		 8,927 2022-02-18 0

    HILT DANA CHARLES CHIEF MEDICAL OFFICER

    • Officer
    		 30,000 2021-04-20 0

    BOOKMAN MICHAEL GENERAL COUNSEL AND SECRETARY

    • Officer
    		 30,000 2021-04-20 0

    FLYNN JAMES E

    DEERFIELD MGMT L.P.

    DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

    DEERFIELD SPECIAL SITUATIONS FUND, L.P.

    DEERFIELD MGMT IV, L.P.

    DEERFIELD PRIVATE DESIGN FUND IV, L.P.

    DEERFIELD PARTNERS, L.P.

    • 10% Owner
    • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
    		 No longer subject to file 2019-10-07 0

    ALEXANDRIA VENTURE INVESTMENTS, LLC

    • 10% Owner
    		 No longer subject to file 2019-10-07 0

    FLYNN JAMES E

    DEERFIELD MGMT IV, L.P.

    DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

    DEERFIELD PRIVATE DESIGN FUND IV, L.P.

    DEERFIELD MGMT L.P.

    DEERFIELD SPECIAL SITUATIONS FUND, L.P.

    • 10% Owner
    • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
    		 0 2019-10-02 0

    KARP JEFFREY M.

    • 10% Owner
    		 296,934 2019-10-02 0

    MCLEAN WILLIAM J.

    • 10% Owner
    		 296,934 2019-10-02 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    FREQUENCY THERAPEUTICS INC FREQ 2023-06-07 12:45:04 UTC 2.7184 2.3516 600000
    FREQUENCY THERAPEUTICS INC FREQ 2023-06-06 22:15:03 UTC 2.7184 2.3516 600000
    FREQUENCY THERAPEUTICS INC FREQ 2023-06-06 21:45:05 UTC 2.7184 2.3516 600000
    FREQUENCY THERAPEUTICS INC FREQ 2023-06-06 21:15:04 UTC 2.7184 2.3516 600000
    FREQUENCY THERAPEUTICS INC FREQ 2023-06-06 20:45:04 UTC 2.7184 2.3516 600000
    FREQUENCY THERAPEUTICS INC FREQ 2023-06-06 20:15:04 UTC 2.7184 2.3516 600000
    FREQUENCY THERAPEUTICS INC FREQ 2023-06-06 19:45:04 UTC 2.7184 2.3516 600000
    FREQUENCY THERAPEUTICS INC FREQ 2023-06-06 19:15:03 UTC 2.7184 2.3516 600000
    FREQUENCY THERAPEUTICS INC FREQ 2023-06-06 18:45:04 UTC 2.7184 2.3516 600000
    FREQUENCY THERAPEUTICS INC FREQ 2023-06-06 18:15:04 UTC 2.7184 2.3516 600000
    FREQUENCY THERAPEUTICS INC FREQ 2023-06-06 17:45:04 UTC 2.7184 2.3516 600000
    FREQUENCY THERAPEUTICS INC FREQ 2023-06-06 17:15:04 UTC 2.7184 2.3516 600000
    FREQUENCY THERAPEUTICS INC FREQ 2023-06-06 16:45:04 UTC 2.7192 2.3408 600000
    FREQUENCY THERAPEUTICS INC FREQ 2023-06-06 16:15:03 UTC 2.7192 2.3408 600000
    FREQUENCY THERAPEUTICS INC FREQ 2023-06-06 15:45:04 UTC 2.7192 2.3408 600000
    FREQUENCY THERAPEUTICS INC FREQ 2023-06-06 15:15:04 UTC 2.7192 2.3408 600000
    FREQUENCY THERAPEUTICS INC FREQ 2023-06-06 14:45:04 UTC 2.7107 2.3493 600000
    FREQUENCY THERAPEUTICS INC FREQ 2023-06-06 14:15:03 UTC 2.7107 2.3493 600000
    FREQUENCY THERAPEUTICS INC FREQ 2023-06-06 13:45:03 UTC 2.7107 2.3493 600000
    FREQUENCY THERAPEUTICS INC FREQ 2023-06-06 13:15:03 UTC 2.7107 2.3493 550000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund FREQ -2500.0 shares, $-1257.5 2023-03-31 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments